Investment Considerations GEMXX has a qualified Regulation A offering in place to raise up to $6 million at $0.40 per share. GEMXX’s net income for the three months ended December 31, 2022, increased to $182,992, as compared to $126,360 in the previous quarter. The company’s most recent financial results filing continues to report positive net … Continue reading “GEMXX Corp. (OTC: GEMZ)”
Company committed to building presence in U.S. and Europe to advance mission of improving mental health care New appointments will strengthen Cybin’s development and clinical operations globally, solidify position within the industry New leaders bring broad experience, deep insight to their new roles Cybin (NEO: CYBN) (OTCQB: CLXPF), a leading biotech company focused on progressing … Continue reading “Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Looks to New Senior Management with Expertise in Development, Clinical Capabilities”
HempFusion Wellness Inc. is currently in the process of applying for OTCQX listing and DTC eligibility after a swift and strategic move to enter the OTC Pink Market under the ticker symbol ‘CBDHF’ Wholly owned subsidiary Probulin Probiotics recently released Total Care Immune probiotic, which is expected to reach retailer shelves in February 2021 Probulin … Continue reading “HempFusion Wellness Inc. (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO) Begins 2021 Strong with OTC Market Listing, New Product, and USDA Organic Certification”
Bitcoin
Bitcoin Cash
Dogecoin
Ethereum
Litecoin
USD Coin
Copyright . NetworkNewsWire® / 8033 Sunset Blvd Suite 1037 Los Angeles, CA 90046 (212) 418-1217 / Disclaimers
